If patients are found to have an aneurysm on angiography, then SAH is confirmed and definitive management follows. However, if CTA is nondiagnostic, there are a few possibilities. Approximately 15% of patients with SAH have a nonaneurysmal cause of hemorrhage. 28 These cases can be divided into 1) those with positive findings on head CT with or without a perimesencephalic blood distribution and 2) those with negative findings on head CT but positive findings on LP. 2 The results of CSF evaluation can be true positive due to SAH or falsely positive due to a traumatic LP.
The risk of subsequent SAH in patients with SAH on CT and negative CTA has been described in multiple series. 3, 5, 15, 18, 19, 28, 29 Perimesencephalic nonaneurysmal SAH has a good short-and long-term prognosis. Nonperimesencephalic nonaneurysmal SAH has a varied etiology and prognosis, and the prognosis partly depends on the distribution and extent of hemorrhage. 2, 19, 27 However, the risk of subsequent SAH with bloody CSF (presence of xanthochromia or > 5 RBCs/mm 3 in CSF from LP) and negative results on modern CT or CTA is not well described. 2, 18, 27 Multidetector CTA is considered to be excellent in the detection of aneurysms 1, 9, 13, 34 and has been estimated to have a sensitivity of 99.4% in detecting ruptured aneurysms compared with intraoperative findings. 24 CTA can sometimes detect aneurysms missed by CT/LP 6 and digital subtraction angiography (DSA). 3 We hypothesized that acute headache patients with negative findings on noncontrast head CT and an LP positive for CSF RBCs who have no aneurysm or neurovascular lesion on cerebrovascular imaging are at low risk for subsequent catastrophic SAH. If this is true, then it will confirm the safety of the current practice of discharging these patients home. It also allows further consideration of an alternative diagnostic algorithm of CT/CTA in lieu of CT/ LP to assess for acute SAH or risk of imminent SAH in appropriate patients presenting to the ED with headache. Our primary goal in this investigation is to determine whether the combination of CT and CTA of the head is sufficiently sensitive to assess for acute aneurysmal SAH or increased risk of future SAH in patients with bloody CSF.
Methods

Study Design
This was a retrospective case series of all consecutive adult patients who incurred charges for an LP performed in the ED of Massachusetts General Hospital between 2001 and 2009 and had headache, bloody CSF, and negative findings on neurovascular imaging. The study was approved by the hospital's institutional review board (IRB), with exemption from informed consent, and was conducted between 2010 and 2011.
Study Setting and Patient Population
The setting was a single urban academic hospital with over 90,000 annual ED visits, which serves as a tertiary care referral center for neurosurgical emergencies. A list of all ED patients who were older than 16 years of age and incurred a charge for an LP between 2001 and 2009 was generated and reviewed for 3 inclusion criteria: 1) a complaint of headache, 2) > 5 RBCs/mm 3 CSF in all LP tubes, and 3) cerebrovascular imaging (CTA or MRA) within 2 weeks of the ED visit.
Exclusion criteria included: depressed consciousness such that the patient was unable to indicate having a headache, ED fever with temperature above 100.5°F, unsuccessful LP, LP performed at another facility, LP primarily performed for cytology evaluation, LP with culture-positive meningitis, neurovascular imaging with evidence of intracranial hemorrhage (ICH), aneurysm, or vascular lesion, presence of a ventriculoperitoneal shunt, head trauma within 2 weeks of the ED visit, neurosurgery within 4 weeks prior to the ED visit, or less than 6 months of clinical follow-up available after the initial ED visit.
Fever was an exclusion criterion because although patients with SAH may have secondary fever as part of their clinical presentation, we wanted to eliminate patients who might have meningitis. Those who had a history concerning for meningitis would clearly need further evaluation or admission and would not be low-risk patients who could safely be discharged.
Imaging
Brain imaging was performed in the ED with 16-or 64-slice CT scanners (GE Medical Systems) and a 1.5-T MR scanner (GE Medical Systems).
Study Protocol
Screening of all computer records generated by a search for billing codes for LP were performed by 4 nonblinded reviewers to determine whether patients met the inclusion criteria. Exclusion criteria were assessed in 2 tiers. Most exclusion criteria were assessed with this initial screening of the computer record. A few exclusion criteria-including presence of ED fever with temperature above 100.5°F; culture-proven meningitis; evidence of ICH, aneurysm, or vascular lesion; and less than 6 months of follow-up-required further detailed review of the medical record, and these cases were assessed upon comprehensive medical record review.
Comprehensive medical record review of all patients who met the initial inclusion and exclusion criteria was performed by 2 unblinded emergency physician reviewers, who abstracted data by consensus using a standardized protocol and data collection instrument. Data collected included: date and time of ED presentation; demographic characteristics; duration, quality, and circumstances of headache, and associated symptoms; medical history (hypertension, chronic headache disorders, history of SAH, cerebrovascular disease or malignancy, polycystic kidney disease, vasculitis, smoking history, warfarin, aspirin, clopidogrel use); relevant family history; physical examination findings of neck stiffness or neurological abnormalities; maximum ED temperature; date and time of LP performance; results of CSF analysis; and all neuroimaging results. If a finding such as photophobia was not specifically mentioned in the record, it was noted as such, but ultimately treated as absent.
Standardized follow-up consisting of 3 questions was performed for all patients without exclusion criteria: 1) the presence of new atraumatic ICH subsequent to the visit, 2) the presence of a new cerebral vascular lesion subsequent to the visit, and 3) any adverse events related to the ED visit including complications of SAH such as new seizures or hydrocephalus and complications post-LP or CTA.
The follow-up process was performed according to the IRB-approved protocol in 2 phases. 1) Patients who presented for any follow-up care to one of over 20 local hospitals/clinics within the "Partners" network, the largest such network in the state, which shares an electronic health information system (longitudinal medical record [LMR]) with the study institution, had systematic computerized medical record review of all visit notes, admission/discharge summaries, neuroimaging studies, and operative reports to determine responses to the above questions. 2) Patients who did not receive any documented follow-up in the electronic Partners LMR were contacted by telephone. First, a letter, along with a self-addressed return card, was sent to the patient signed by the ED vice chairman and administrative director and study investigator, informing the patient about the study objective and requesting a response to accept or decline contact. If the patient approved contact or no response was received within 2 weeks, then up to 3 attempts were made to contact the patient by telephone to obtain answers to the 3 follow-up questions listed above using a standardized telephone script.
If the patient could not be reached by telephone, the following strategies were used sequentially to attempt follow-up: 1) calling the emergency contact number, 2) calling the primary care physician to find a valid patient contact number, 3) performing a Google search with the patient's name (and sometimes also home state in cases of multiple results), and finally 4) searching the US Social Security Death Index.
Because our objective was to determine long-term clinical outcome for patients presenting with headache and abnormal CSF results with normal vascular imaging, patients who did not have follow-up available for at least 6 months after their ED visit were considered to have inadequate follow-up and were excluded. These patients were still followed up to the maximum number of months available to exclude SAH/vascular lesion in that period of less than 6 months, and they were assessed for death in the Social Security Death Index. All patient deaths were investigated to determine if the death may have been related to an acute SAH.
Two blinded emergency physicians each reviewed a different half of all of the charts that were subjected to comprehensive review to assess for reliability of data extraction. They collected data on the following variables: elements related to the headache presentation, physical examination, medical history, and family history, as listed previously, as well as time from symptom onset to LP, CSF results (number of RBCs/mm 3 in the first tube, number of RBCs/mm 3 in the last tube, xanthochromia), maximum ED temperature, all neuroimaging results (head CT/CTA, neck CTA, head MRI/MRA, neck MRI/ MRA, conventional angiogram), and follow-up information available by medical record review (subsequent ICH, subsequent aneurysm/neurovascular lesion).
When there were discrepancies between the blinded and nonblinded review, a third emergency physician reviewed the data to determine the final outcome.
Outcome Measures
The primary outcomes were 1) any subsequent nontraumatic SAH and 2) any new aneurysm, arteriovenous malformation, or other cerebrovascular lesion. We also made note of all cases of subsequent ICH. Secondary outcomes were any reported complications from SAH in addition to rebleeding and procedural complications within 2 weeks of the LP (headache, back pain, infection, neurological symptoms, other) or CTA (allergic reaction, contrast nephropathy, other) requiring medical care.
Data Analysis
The study was powered for a 95% confidence interval span of no more than 2% (0% to 2%) if no primary outcome events were observed. Summary statistics were computed with SPSS-17 (IBM, Inc.). For binomial results, exact confidence intervals were computed with StatXact-3 (Cytel Software). Reliability analyses were computed using unweighted kappa statistics and intraclass correlation coefficients for nominal and interval data, respectively.
Results
Characteristics of Study Subjects
Computer records of 4462 consecutive ED patients older than 16 years of age who had an LP performed between 2001 and 2009 were initially reviewed. Of these 4462 patients, 1193 had no headache. Of the remaining 3269 patients, 2133 did not have bloody CSF on LP. Of the 1136 patients with headache and bloody CSF, 824 received no angiographic examination, and 32 were excluded from the study for other reasons. Two hundred eighty patients with headache, > 5 RBCs/mm 3 in the final CSF tube, neurovascular imaging (CTA, MRA), and none of the first-tier exclusion criteria were eligible for comprehensive chart review (Fig. 1 ). Of these, 181 patients were included who met all inclusion/exclusion criteria and had long-term follow-up (Table 1) . Five patients were lost to follow-up and none were identified in the Social Security Death Index. Patients presented at a median time of 2 days after their headache onset. Eighty-one percent of patients had neurovascular imaging within 1 calendar day of the ED visit and LP (median 0 days, interquartile range [IQR] 0-1 day).
Main Results
Over a median follow-up of 53 months (IQR 27.5-79.0 months), 0 of 181 patients (0%, 95% CI 0%-2.0%) had a primary outcome of subsequent nontraumatic SAH. There were 4 cases of subsequent new intraparenchymal hemorrhage in follow-up, 3 related to trauma. The single nontraumatic case involved a patient who returned 2 weeks after the index ED visit with new hemiparesis and was found to have vasculitis, which was subsequently complicated by petechial intraparenchymal hemorrhage. The other primary outcome of a subsequent new vascular lesion was found in 0 of 181 patients (0%, 95% CI 0%-2.0%).
We did not identify any patients with new seizures or hydrocephalus related to their ED visit. With respect to the secondary procedural outcomes, 18 (9.9%) of 181 patients (95% CI 6.0%-15.3%) had an LP-related complication, including headache (in 15 cases), neck/back pain (in 2), or leg pain (in 1), and 0 (0%) of 181 patients (95% CI 0%-2.0%) had an angiography-related complication such as allergic reaction or contrast nephropathy.
There were 5 patients who were found to be deceased during follow-up. The cause of death in the single patient who died within the 6-month follow-up period was thought to be complications from an ischemic stroke. He presented with mild headache and confusion, and an inpatient MRI demonstrated multiple nonhemorrhagic infarcts after the patient's initial ED presentation. CTA showed a right M 2 inferior branch cutoff and no aneurysms. Stroke service evaluation included an LP with 6 RBCs/mm 3 and 2 white blood cells (WBCs)/mm 3 in the final tube. A transesophageal echocardiogram demonstrated cardiomyopathy with left ventricular thrombus, which was thought to be the source of embolic strokes. The patient's hospital course was complicated by witnessed aspiration and sepsis, and the patient died within 2 months of the initial ED visit. The other 4 deaths were not related to SAH.
Data reliability analysis was performed on all reported variables for all 280 patients, except for the follow-up results, which were collected for only 137 patients with long-term follow-up by computer record. All reliability values were greater than 0.80 except for those for the following variables: findings on conventional angiogram (κ = 0.74), evidence of subsequent ICH on medical record follow-up (κ = 0.39), evidence of subsequent aneurysm/ neurovascular lesion on medical record follow-up (κ unable to be calculated because no positive results), and evidence of post-LP complications (κ = 0.71).
Discussion
The results of this study support the common clinical assumption that patients with bloody CSF but negative CTA/MRA generally have a good prognosis, do not require further emergent diagnostic evaluation, and can safely be discharged home, if other emergent workup is not being considered. Although we expected CTA to be more commonly used, the neurovascular imaging in this study is distributed almost evenly between CTA and MRA. Comparable sensitivity between CTA and MRA is assumed. 4, 16, 30, 33 Although not the main focus of our study, among over 3000 patients who received an LP for headache after negative findings on head CT over 8 years in our ED, ultimately only 4 patients were diagnosed with SAH based on LP results alone after negative results on noncontrast head CT. Diagnosis was made in conjunction with neurovascular imaging. This illustrates a low yield of the current CT/LP strategy at our institution.
In essence, whether the LP demonstrates bloody CSF, the disposition and prognosis seem to be most strongly determined by the results of the noncontrast head CT and CTA. Thus, it seems logical to consider an alternative diagnostic strategy. For patients with suspected SAH and negative findings on noncontrast CT, such a strategy might be to perform primary CTA in lieu of LP.
Our result is also in concurrence with a recent study that estimated the risk of a missed aneurysmal SAH after a CTA with negative findings to be 1% or less by mathematical modeling. 22 A single prospective study of patients with clinical presentations suggestive of SAH has been performed directly comparing CT/CTA with CT/ LP in 106 patients. 6 Based on strict criteria, 2 patients had positive results of LP, and in both cases aneurysms were revealed by CTA and confirmed by DSA. In 100 patients, the results of both LP and CTA were negative, and it is unknown if any of these patients suffered subsequent bleeds.
There are caveats to the use of the proposed alternative diagnostic strategy. Physicians cannot forgo LP if other conditions are being considered for which LP is crucial for diagnosis, such as meningitis, idiopathic intracranial hypertension, or intracranial hypotension.
If CTA is used after CT in lieu of LP, then nonaneurysmal SAH with negative findings on head CT would not be identified. For patients with nonaneurysmal SAH identified on CT, prognosis seems inversely associated with the volume of hemorrhage. 2, 19, 27 Although not previously proven, considering these data, it seems reasonable that patients with CSF hemorrhage identified only by LP without hemorrhage or vascular lesion visualized by head CT/CTA also have a good long-term prognosis.
CTA interpretation is important for sensitivity and depends on the experience of the radiologist. 17 Although not found in this study, the use of CTA may be associated with complications from the intravenously administered contrast agent, such as allergic reaction or contrast agentinduced nephropathy, and those patients with low glomerular filtration rates may require exclusion from a pathway * Values represent numbers of patients (%) unless otherwise indicated. † Analysis is based on a total of 179 patients for historical factors and physical examination variables because 2 paper charts were missing. ‡ Neurological abnormalities: unilateral weakness (13), unilateral sensory loss (4), disorientation (3), aphasia (2), visual deficit (7), unsteady gait (1).
featuring angiography. The risk of ionizing radiation and comparative costs are also factors to consider. It is estimated that about 2% of the general population harbors cerebral aneurysms. 26 When an aneurysm is detected on CTA with the CT/CTA approach, further workup must be performed to determine whether the aneurysm is ruptured, and this may include LP to determine whether there is bloody CSF and/or xanthochromia. If the aneurysm is unruptured, then an incidental finding may lead to additional evaluation with attendant risk and expense. However, there may be some benefit to identifying the aneurysm if it were deemed to be a symptomatic lesion, because in these cases, there is an 8-fold risk of rupture compared with asymptomatic incidental aneurysms. 26 Despite caveats, the concept of alternative diagnostic strategies merits consideration. Implementing this approach would be anticipated to lead to more CTAs and fewer LPs among patients with headache who present to EDs. Avoiding LPs may mean less pain, less evaluation time for the patient and physician, less horizontal time (patients may receive ongoing evaluation and care without requiring a stretcher), improved flow in the ED, fewer neurosurgical consultations, and fewer cases of post-LP headache or other rare but serious LP complications.
Recent evidence even suggests that within 6 hours of headache onset, noncontrast head CT alone may be used to rule out SAH. 25 Ultimately, clinical judgment will also need to be used to determine whether a patient is safe for discharge or further testing is warranted.
This retrospective study suggests that a subsequent catastrophic SAH is unlikely in patients who present to an ED with headache and have normal findings on head CT/CTA. Thus, there may be sufficient safety and clinical equipoise to merit a prospective trial comparing a CT/LP versus a CT/CTA diagnostic approach.
If a CT/CTA diagnostic approach proves efficacious, future studies are needed to better delineate the patient population in which such a strategy might be employed. We would not view it as necessarily a better diagnostic strategy, but rather an apparently safe alternative approach, useful in certain situations. Such an approach might be particularly useful for patients who refuse LP, for patients with a critical requirement for anticoagulation (such as those with left-sided mechanical valves), or in those with spinal disease in whom an LP might be technically difficult. Clinical criteria for ruling out meningitis and identifying patients in whom LP can be omitted without missing infection represent an important area for further clarification. Finally, the optimal management of incidentally found aneurysms and whether such an aneurysm is symptomatic requires further study.
Limitations
Some patients included in this study may not seem to be at high risk for SAH. The included patients had a median of 600 RBCs/mm 3 11 Thirteen patients had xanthochromia. Xanthochromia may not develop for 12 hours after headache onset, and this test alone may be insufficiently sensitive for SAH. 21 Thirty patients (17%) demonstrated neurological abnormalities (Table 1) . Overall, the 181-patient group appeared to be at moderate risk for SAH. While patients with headache and bloody LP warranting neurovascular imaging represent the ED group at highest risk for SAH despite negative findings on head CT, this underscores the difficulty in identifying a truly high-risk group in the modern era of sensitive multidetector head CT imaging.
Conversely, 824 patients with > 5 RBCs/mm 3 in the final tube received no neurovascular imaging and were thus excluded from further analysis. This raises the possibility of selection bias and missed aneurysmal hemorrhage. Analyses of LP data were obtained on a random sample of 100 of these excluded patients. The first and final tube median RBC counts were 311 cells/mm ). In 31 of the 100 samples selected for further analysis, the additional analysis showed an elevated WBC count consistent with meningitis. Overall, these LP characteristics suggest the patients were at low risk for aneurysmal SAH and neurovascular imaging was appropriately deferred.
There are several other limitations of our study related to its retrospective nature. It is possible an LP may have been performed but no LP billing code was generated in a small number of cases, and the patients involved would not have been identified by our search. For some of the variables characterizing the patient's history and nature of headache, we are limited by the paucity of information reported in some medical records; however this does not affect our objective criteria of LP and CTA or MRA findings. While CTA and MRA have been shown to have high sensitivity and specificity for detecting aneurysms, this was not specifically tested in our study.
Both primary and secondary outcomes could have been underestimated if patients presented to facilities outside of the study institution's network of hospitals and the event was not reported in the Partners medical record. Furthermore, patients may not be able to remember adverse events from LP/CTA with such delayed follow-up leading to recall bias.
Although our reliability analysis revealed good agreement between reviewers on almost all variables, for the variable of subsequent ICH on medical record follow-up, κ was especially low (0.39) because of 3 cases of disagreement. All reviewers agreed on the 135 cases negative for ICH and on 1 case positive for ICH. However, there were 2 additional cases of ICH found by the blinded reviewer (the vasculitis case mentioned above and 1 trauma-related case), and 1 traumatic ICH case found by the nonblinded reviewer, which was missed by the blinded reviewer. The primary outcome, nontraumatic SAH, was not identified by any reviewer. It is known that the kappa statistic can be inordinately decreased when the marginal values are imbalanced. 14 The overall agreement proportion was 98% (136 of 139 cases).
Conclusions
Patients who present to the emergency department with a headache and have a normal head CT but bloody CSF on LP are at low risk for subsequent SAH if they also have normal neurovascular imaging. These patients are likely safe for discharge unless they need further evaluation for other conditions. Further prospective study is warranted to determine whether cerebrovascular imaging, such as CTA alone after CT, may be a safe and efficacious alternative approach to rule out suspected aneurysmal SAH at risk for subsequent bleeding.
